MSD’s success as one of the planet’s leading pharmaceutical multinationals is driven by a singular vision: to be a formidable force for good in the world by saving human and animal lives. With this aim in mind, the business embarked on Project Streamline, a multi-partner, enterprise-wide transformation programme designed to upgrade and standardise its procurement processes. Launched in 2018, it subsequently became one of the largest, most complex SAP Ariba-based procurement transformations ever implemented.
EY acted as MSD’s Implementation Partner from the start of this four-year programme, which covered 71 countries worldwide.
Global programmes of this magnitude are never for the faint-hearted. Not only did Project Streamline involve working across borders and time zones, but teams also had to deal with a mix of languages, cultures, functions, organisational structures and regulatory landscapes – among other challenges. To complicate matters, the Project Streamline team also had to contend with the COVID-19 pandemic, which placed particularly heavy demands on its communication capabilities.
These challenges only brought out the very best in the 100+-strong project team. Collaborating closely with the MSD teams throughout the process, we overcame these obstacles to deliver the best possible outcome in rolling out a fully integrated, globally standardised source-to-settle platform covering many thousands of and suppliers across the Globe.
Project Streamline also delivered above-target bottom-line savings ahead of plan, which MSD can now invest into realising its vision by researching and developing new health solutions, medicines, vaccines and biologic therapies for humans and animals.
View the EY profile in the MCA Members Directory.